Fetal EchoScan

K242342

BrightHeart · cleared 2024-11-14 · product code POK · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.5)
Fetal EchoScan is a cloud-based software-only device which uses neural networks to detect suspicious cardiac radiographic findings for further review by trained and qualified physicians.
Algorithmneural networks
source quote (p.5)
Fetal EchoScan is a cloud-based software-only device which uses neural networks to detect suspicious cardiac radiographic findings for further review by trained and qualified physicians.
Adaptive (vs locked)FDA source did not state this
PCCPFDA source did not state this
Cybersecurity addressedYes
source quote (p.8)
Cybersecurity documentation was provided as recommended by FDA's Guidance for Industry and FDA Staff, “Content of Premarket Submissions for Management of Cybersecurity in Medical Devices”.

Validation studies (2)

Standalone

n=877 cases · 11 site(s)

endpoints: Sensitivity; Specificity

standards: IEC 62304:2016

Reader study (MRMC)

n=200 cases

endpoints: ROC AUC; Sensitivity; Specificity

Reported performance (13 observations)

sensitivity0.977CI 0.954; 0.989
source quote (p.10)
0.977 (0.954; 0.989)
specificity0.977CI 0.961; 0.987
source quote (p.10)
0.977 (0.961; 0.987)
aurocas written: “auc0.974CI 0.957; 0.990
source quote (p.11)
0.974 (0.957; 0.990)
sensitivityas written: “Sensitivity (Best-Case) for Any suspicious findings (Inconclusive Exams Counted as Positive)0.987CI 0.967; 0.995
source quote (p.10)
0.987 (0.967; 0.995)
specificityas written: “Specificity (Worst-Case) for Any suspicious findings (Inconclusive Exams Counted as Positive)0.963CI 0.944; 0.976
source quote (p.10)
0.963 (0.944; 0.976)
aurocas written: “Model Estimate AUC (95% CI) for Overriding artery (Aided)0.953CI 0.916; 0.990
source quote (p.11)
0.953 (0.916; 0.990)
aurocas written: “Model Estimate AUC (95% CI) for Cardiac crux septal defect (Aided)0.971CI 0.943; 0.999
source quote (p.11)
0.971 (0.943; 0.999)
aurocas written: “Model Estimate AUC (95% CI) for Abn. OT relationship (Aided)0.972CI 0.953; 0.992
source quote (p.11)
0.972 (0.953; 0.992)
aurocas written: “Model Estimate AUC (95% CI) for Enlarged CTR (Aided)0.96CI 0.930; 0.989
source quote (p.11)
0.960 (0.930; 0.989)
aurocas written: “Model Estimate AUC (95% CI) for Cardiac axis deviation (Aided)0.967CI 0.932; 1.000
source quote (p.11)
0.967 (0.932; 1.000)
aurocas written: “Model Estimate AUC (95% CI) for PV/AV size discrepancy (Aided)0.979CI 0.962; 0.997
source quote (p.11)
0.979 (0.962; 0.997)
aurocas written: “Model Estimate AUC (95% CI) for RV/LV size discrepancy (Aided)0.991CI 0.983; 0.999
source quote (p.11)
0.991 (0.983; 0.999)
aurocas written: “Model Estimate AUC (95% CI) for TV/MV size discrepancy (Aided)0.964CI 0.938; 0.990
source quote (p.11)
0.964 (0.938; 0.990)

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
0
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
2
drift signals on this device
  • re_clearance

    The FDA AI/ML device list shows a newer 510(k) K252294 (decision 2025-12-08) from Brightheart for a matching device line ("Fetal EchoScan (v1.2)") — a new clearance for the same line is a change event.

    first seen 2026-07-08 · k_number:K252294

  • re_clearance

    The FDA AI/ML device list shows a newer 510(k) K251071 (decision 2025-05-02) from BrightHeart for a matching device line ("Fetal EchoScan (v1.1)") — a new clearance for the same line is a change event.

    first seen 2026-07-08 · k_number:K251071

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K242342